azitrainc.com (AZTR) - Cash per Share

Azitra, Inc. (AZTR) relies on a cohesive team of microbiologists, as confirmed by the cash per share analysis on GURU.Markets, where 0.63 reflects the latest value of the metric. The company monetizes unique treatment methods for dermatological pathologies, ensuring financial stability. Furthermore, strategic alliances with scientific centers developing GMO-based drugs significantly enhance the business's investment attractiveness for future M&A transactions.
Comprehensive metric breakdowns and analytics for Azitra Inc (AZTR)

For a portfolio manager, this indicator serves as a measure of the issuer's financial viability. The calculation, derived by dividing total cash holdings by the number of shares, determines the liquidity available per share. By analyzing cash per share, an investor can gauge the capital burn rate. For Azitra, Inc. (AZTR), this metric is critical due to the development costs of microbiome drugs. This chart reflects the company's margin of safety within the dermatological biotechnology niche.